Metaxalone and Chronic kidney disease - a phase IV clinical study of FDA data
Chronic kidney disease is found among people who take Metaxalone, especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years.
The phase IV clinical study analyzes which people take Metaxalone and have Chronic kidney disease. It is created by eHealthMe based on reports of 3,664 people who have side effects when taking Metaxalone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
3,664 people reported to have side effects when taking Metaxalone.
Among them, 110 people (3.0%) have Chronic kidney disease.
What is Metaxalone?
Metaxalone has active ingredients of metaxalone. It is often used in back pain - low. eHealthMe is studying from 3,829 Metaxalone users for its effectiveness, alternative drugs and more.
What is Chronic kidney disease?
Chronic kidney disease is found to be associated with 2,104 drugs and 1,089 conditions by eHealthMe.
Number of Metaxalone and Chronic kidney disease reports submitted per year:
Time on Metaxalone when people have Chronic kidney disease *:
Gender of people who have Chronic kidney disease when taking Metaxalone*:
Age of people who have Chronic kidney disease when taking Metaxalone *:
Common drugs people take besides Metaxalone *:
Common side effects people have besides Chronic kidney disease *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Metaxalone and have Chronic kidney disease?Check whether Chronic kidney disease is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Aalaei-Andabili, S. H., Umer, M., & Keeley, E. C., "An Adult Woman With Stage 4 Chronic Kidney Disease and a Diffuse Rash", JAMA cardiology, 2019 Jan .
Alternative drugs to, pros and cons of Metaxalone:
- Metaxalone (3,829 reports)
Chronic kidney disease treatments and more:
- Chronic kidney disease (116,666 reports)
COVID vaccines that are related to Chronic kidney disease:
- Chronic kidney disease in Moderna COVID Vaccine
- Chronic kidney disease in Pfizer BioNTech Covid Vaccine
- Chronic kidney disease in Johnson and Johnson Covid Vaccine
How severe was Chronic kidney disease and when was it recovered:
Expand to all the drugs that have ingredients of metaxalone:
Common drugs associated with Chronic kidney disease:
All the drugs that are associated with Chronic kidney disease:
- Chronic kidney disease (2,104 drugs)
Common conditions associated with Chronic kidney disease:
All the conditions that are associated with Chronic kidney disease:
- Chronic kidney disease (1,089 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on metaxalone (the active ingredients of Metaxalone) and Metaxalone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.